Abstract
Galvanize Therapeutics, a specialist in energy-based medical devices, has announced a merger with two other firms developing pulsed electric field technology and the raising of $100 million in series B financing. Galvanize will put the cash toward advancing its Aliya pulsed electric field energy platform, which it says uses an electrical current to “interfere with cellular function in tissue.” The company’s initial areas of focus are chronic bronchitis, cardiac arrhythmia, oncology, and drug delivery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
